Analysis of tumor tissues at endpoint revealed that both U87 FAP+ and U251 FAP− cells were reduced following FAP‐CAR‐T cell treatment, suggesting that the CAR‐T cells exert longitudinal control over both U251 and U87 cells, in keeping with our in vitro findings of bystander killing. The gene discussed is FAP; the disease is neoplasm.